Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P230014/S004

Lumicell Direct Visualization System (DVS)

Lumicell, Inc. · Decision date Nov 25, 2025

FDA DECISIONP230014/S004

What did the FDA approve?

FDA records P230014/S004 as a supplement to PMA P230014, with the supplement type “Special (Immediate Track)”. The recorded decision is approval, dated Nov 25, 2025.

FDA approval order statement

Approval for changes to the labeling including additional caution/warning/guidance statements and updated labeling to address corrective actions taken with respect to breaking or detachment of elastic bands from the device during use.
Regulatory pathway
PMA supplement
Supplement type
Special (Immediate Track)
Clinical specialty
General, Plastic Surgery
Decision date
Nov 25, 2025
FDA change category
Labeling Change - Indications/instructions/shelf life/tradename

FDA source record

Regulatory record facts

Identifier
P230014/S004
Regulatory pathway
PMA supplement
Product code
SAW
Decision code
APPR
Decision date
Nov 25, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Fluorescence imaging for breast cancer detection.

Product code
SAW
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P230014/S004 received

    Application receipt date recorded by FDA.

  2. P230014/S004 · FDA decision

    Special (Immediate Track)

Timeline entries are records held by MedtechLedger for P230014. View FDA’s full supplement list.

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Lumicell, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
275 Washington St., Suite 200, Newton, MA, 02458

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records